BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7949682)

  • 21. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
    Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E
    Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast.
    Kerslake RW; Carleton PJ; Fox JN; Imrie MJ; Cook AM; Read JR; Bowsley SJ; Buckley DL; Horsman A
    Clin Radiol; 1995 Jul; 50(7):440-54. PubMed ID: 7614789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
    Ross MR; Schomer DF; Chappell P; Enzmann DR
    AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of the brain with gadopentetate dimeglumine-DTPA: comparison of T1-weighted spin-echo and 3D gradient-echo sequences.
    Li D; Haacke EM; Tarr RW; Venkatesan R; Lin W; Wielopolski P
    J Magn Reson Imaging; 1996; 6(3):415-24. PubMed ID: 8724406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
    Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
    Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and staging of chondromalacia patellae: relative efficacies of conventional MR imaging, MR arthrography, and CT arthrography.
    Gagliardi JA; Chung EM; Chandnani VP; Kesling KL; Christensen KP; Null RN; Radvany MG; Hansen MF
    AJR Am J Roentgenol; 1994 Sep; 163(3):629-36. PubMed ID: 8079858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bowel disease: prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences.
    Semelka RC; Shoenut JP; Silverman R; Kroeker MA; Yaffe CS; Micflikier AB
    J Magn Reson Imaging; 1991; 1(6):625-32. PubMed ID: 1823167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium-enhanced T1-weighted versus T2-weighted imaging of scrotal disorders: is there an indication for MR imaging?
    Müller-Leisse C; Bohndorf K; Stargardt A; Sohn M; Neuerburg J; Adam G; Wein B; Urhahn R; Günther RW
    J Magn Reson Imaging; 1994; 4(3):389-95. PubMed ID: 8061438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla.
    Dean KI; Komu M; Dean PB; Kormano M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S302-3. PubMed ID: 7928264
    [No Abstract]   [Full Text] [Related]  

  • 37. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.
    Boetes C; Mus RD; Holland R; Barentsz JO; Strijk SP; Wobbes T; Hendriks JH; Ruys SH
    Radiology; 1995 Dec; 197(3):743-7. PubMed ID: 7480749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
    Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
    Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
    Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
    Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.